Cargando…
Bio-Engineered Nisin with Increased Anti-Staphylococcus and Selectively Reduced Anti-Lactococcus Activity for Treatment of Bovine Mastitis
Bovine mastitis is a significant economic burden for dairy enterprises, responsible for premature culling, prophylactic and therapeutic antibiotic use, reduced milk production and the withholding (and thus wastage) of milk. There is a desire to identify novel antimicrobials that are expressly direct...
Autores principales: | Field, Des, Considine, Kiera, O’Connor, Paula M., Ross, R. Paul, Hill, Colin, Cotter, Paul D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036683/ https://www.ncbi.nlm.nih.gov/pubmed/33801752 http://dx.doi.org/10.3390/ijms22073480 |
Ejemplares similares
-
In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms
por: Field, Des, et al.
Publicado: (2016) -
A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius
por: Field, Des, et al.
Publicado: (2015) -
Studies with bioengineered Nisin peptides highlight the broad‐spectrum potency of Nisin V
por: Field, Des, et al.
Publicado: (2010) -
Bioengineering of a Nisin A‐producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z
por: Piper, Clare, et al.
Publicado: (2011) -
Intensive Mutagenesis of the Nisin Hinge Leads to the Rational Design of Enhanced Derivatives
por: Healy, Brian, et al.
Publicado: (2013)